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Introduction
The workshop on "The Evaluation of
Chemical Mutagenicity Data in Relation to
Population Risk" was held at the Governor's
Inn, Research Triangle Park, North Carolina,
on April 26-28, 1973, under the auspices of
The National Institute of Environmental
Health Sciences. The meeting was organized
by Dr. Frederick J. de Serres, Chief of the
Mutagenesis Branch at The National Insti-
tute of Environmental Health Sciences, with
the cooperation of Dr. W. Gary Flamm, Chief
of the Genetics Toxicology Branch of the
Food and Drug Administration.
Although many of the papers included in
this volume cite experimental data gathered
by use of specific chemical agents, the over-
all aim and the primary objective of the
workshop was directed towards a critical ap-
praisal of the various methodologies for mut-
agenicity testing in current use, rather than
the reporting of effects of individual mut-
agenic substances. Thus, the utility of a me-
thod is often weighed against the counter-
balance of its weaknesses and shortcomings.
This manner of presentation might occasion-
ally seem to lead to opposing recommenda-
tions from different authors. However, it
should be borne in mind that these proceed-
ings are not to be taken as a "cookbook" for
mutagenicity testing, but rather as a guide-
line for avoiding the pitfalls which have al-
ready been detected and for estimating the
reliability of these tests.
That our present tests are limited in scope
and at times unsatisfactory for extrapolating
to the human population is evident from the
many presentations examining the possibili-
ties of newer, more definative systems. While
some of these are theoretical considerations
of the attributes which are desirable and
necessary in a mutagenicity assay, others deal
with actual test methods, the utility of which
are being explored.
The pressing problem and the feature
which generated the most discussion and con-
cern, is how we are to proceed during the
interim period while awaiting the develop-
ment and trial of fully reliable tests. The
consensus is that with thousands of chemicals
currently in use, and the large number of
new substances being developed each year,
we must proceed without delay. We must use
our present knowledge and tests judiciously
and in combinations which might give
greater surity in the estimation of risks.
However, we must not allow ourselves to
become locked into a rigid routine which
will admit to no changes, but rather aim
towards a continued advance in our studies
leading to replacement of systems found
wanting as newer, faster, more certain me-
thods are developed.
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